Cargando…
Tanshinone IIA-Loaded Nanoparticle and Neural Stem Cell Therapy Enhances Recovery in a Pig Ischemic Stroke Model
Induced pluripotent stem cell-derived neural stem cells (iNSCs) are a multimodal stroke therapeutic that possess neuroprotective, regenerative, and cell replacement capabilities post-ischemia. However, long-term engraftment and efficacy of iNSCs is limited by the cytotoxic microenvironment post-stro...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585947/ https://www.ncbi.nlm.nih.gov/pubmed/36124817 http://dx.doi.org/10.1093/stcltm/szac062 |
_version_ | 1784813601878441984 |
---|---|
author | Kaiser, Erin E Waters, Elizabeth S Yang, Xueyuan Fagan, Madison M Scheulin, Kelly M Sneed, Sydney E Cheek, Savannah R Jeon, Julie Heejin Shin, Soo K Kinder, Holly A Kumar, Anil Platt, Simon R Duberstein, Kylee J Park, Hea Jin Xie, Jin West, Franklin D |
author_facet | Kaiser, Erin E Waters, Elizabeth S Yang, Xueyuan Fagan, Madison M Scheulin, Kelly M Sneed, Sydney E Cheek, Savannah R Jeon, Julie Heejin Shin, Soo K Kinder, Holly A Kumar, Anil Platt, Simon R Duberstein, Kylee J Park, Hea Jin Xie, Jin West, Franklin D |
author_sort | Kaiser, Erin E |
collection | PubMed |
description | Induced pluripotent stem cell-derived neural stem cells (iNSCs) are a multimodal stroke therapeutic that possess neuroprotective, regenerative, and cell replacement capabilities post-ischemia. However, long-term engraftment and efficacy of iNSCs is limited by the cytotoxic microenvironment post-stroke. Tanshinone IIA (Tan IIA) is a therapeutic that demonstrates anti-inflammatory and antioxidative effects in rodent ischemic stroke models and stroke patients. Therefore, pretreatment with Tan IIA may create a microenvironment that is more conducive to the long-term survival of iNSCs. In this study, we evaluated the potential of Tan IIA drug-loaded nanoparticles (Tan IIA-NPs) to improve iNSC engraftment and efficacy, thus potentially leading to enhanced cellular, tissue, and functional recovery in a translational pig ischemic stroke model. Twenty-two pigs underwent middle cerebral artery occlusion (MCAO) and were randomly assigned to a PBS + PBS, PBS + iNSC, or Tan IIA-NP + iNSC treatment group. Magnetic resonance imaging (MRI), modified Rankin Scale neurological evaluation, and immunohistochemistry were performed over a 12-week study period. Immunohistochemistry indicated pretreatment with Tan IIA-NPs increased iNSC survivability. Furthermore, Tan IIA-NPs increased iNSC neuronal differentiation and decreased iNSC reactive astrocyte differentiation. Tan IIA-NP + iNSC treatment enhanced endogenous neuroprotective and regenerative activities by decreasing the intracerebral cellular immune response, preserving endogenous neurons, and increasing neuroblast formation. MRI assessments revealed Tan IIA-NP + iNSC treatment reduced lesion volumes and midline shift. Tissue preservation and recovery corresponded with significant improvements in neurological recovery. This study demonstrated pretreatment with Tan IIA-NPs increased iNSC engraftment, enhanced cellular and tissue recovery, and improved neurological function in a translational pig stroke model. |
format | Online Article Text |
id | pubmed-9585947 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-95859472022-10-24 Tanshinone IIA-Loaded Nanoparticle and Neural Stem Cell Therapy Enhances Recovery in a Pig Ischemic Stroke Model Kaiser, Erin E Waters, Elizabeth S Yang, Xueyuan Fagan, Madison M Scheulin, Kelly M Sneed, Sydney E Cheek, Savannah R Jeon, Julie Heejin Shin, Soo K Kinder, Holly A Kumar, Anil Platt, Simon R Duberstein, Kylee J Park, Hea Jin Xie, Jin West, Franklin D Stem Cells Transl Med Enabling Technologies for Cell-Based Clinical Translation Induced pluripotent stem cell-derived neural stem cells (iNSCs) are a multimodal stroke therapeutic that possess neuroprotective, regenerative, and cell replacement capabilities post-ischemia. However, long-term engraftment and efficacy of iNSCs is limited by the cytotoxic microenvironment post-stroke. Tanshinone IIA (Tan IIA) is a therapeutic that demonstrates anti-inflammatory and antioxidative effects in rodent ischemic stroke models and stroke patients. Therefore, pretreatment with Tan IIA may create a microenvironment that is more conducive to the long-term survival of iNSCs. In this study, we evaluated the potential of Tan IIA drug-loaded nanoparticles (Tan IIA-NPs) to improve iNSC engraftment and efficacy, thus potentially leading to enhanced cellular, tissue, and functional recovery in a translational pig ischemic stroke model. Twenty-two pigs underwent middle cerebral artery occlusion (MCAO) and were randomly assigned to a PBS + PBS, PBS + iNSC, or Tan IIA-NP + iNSC treatment group. Magnetic resonance imaging (MRI), modified Rankin Scale neurological evaluation, and immunohistochemistry were performed over a 12-week study period. Immunohistochemistry indicated pretreatment with Tan IIA-NPs increased iNSC survivability. Furthermore, Tan IIA-NPs increased iNSC neuronal differentiation and decreased iNSC reactive astrocyte differentiation. Tan IIA-NP + iNSC treatment enhanced endogenous neuroprotective and regenerative activities by decreasing the intracerebral cellular immune response, preserving endogenous neurons, and increasing neuroblast formation. MRI assessments revealed Tan IIA-NP + iNSC treatment reduced lesion volumes and midline shift. Tissue preservation and recovery corresponded with significant improvements in neurological recovery. This study demonstrated pretreatment with Tan IIA-NPs increased iNSC engraftment, enhanced cellular and tissue recovery, and improved neurological function in a translational pig stroke model. Oxford University Press 2022-09-19 /pmc/articles/PMC9585947/ /pubmed/36124817 http://dx.doi.org/10.1093/stcltm/szac062 Text en © The Author(s) 2022. Published by Oxford University Press. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Enabling Technologies for Cell-Based Clinical Translation Kaiser, Erin E Waters, Elizabeth S Yang, Xueyuan Fagan, Madison M Scheulin, Kelly M Sneed, Sydney E Cheek, Savannah R Jeon, Julie Heejin Shin, Soo K Kinder, Holly A Kumar, Anil Platt, Simon R Duberstein, Kylee J Park, Hea Jin Xie, Jin West, Franklin D Tanshinone IIA-Loaded Nanoparticle and Neural Stem Cell Therapy Enhances Recovery in a Pig Ischemic Stroke Model |
title | Tanshinone IIA-Loaded Nanoparticle and Neural Stem Cell Therapy Enhances Recovery in a Pig Ischemic Stroke Model |
title_full | Tanshinone IIA-Loaded Nanoparticle and Neural Stem Cell Therapy Enhances Recovery in a Pig Ischemic Stroke Model |
title_fullStr | Tanshinone IIA-Loaded Nanoparticle and Neural Stem Cell Therapy Enhances Recovery in a Pig Ischemic Stroke Model |
title_full_unstemmed | Tanshinone IIA-Loaded Nanoparticle and Neural Stem Cell Therapy Enhances Recovery in a Pig Ischemic Stroke Model |
title_short | Tanshinone IIA-Loaded Nanoparticle and Neural Stem Cell Therapy Enhances Recovery in a Pig Ischemic Stroke Model |
title_sort | tanshinone iia-loaded nanoparticle and neural stem cell therapy enhances recovery in a pig ischemic stroke model |
topic | Enabling Technologies for Cell-Based Clinical Translation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585947/ https://www.ncbi.nlm.nih.gov/pubmed/36124817 http://dx.doi.org/10.1093/stcltm/szac062 |
work_keys_str_mv | AT kaisererine tanshinoneiialoadednanoparticleandneuralstemcelltherapyenhancesrecoveryinapigischemicstrokemodel AT waterselizabeths tanshinoneiialoadednanoparticleandneuralstemcelltherapyenhancesrecoveryinapigischemicstrokemodel AT yangxueyuan tanshinoneiialoadednanoparticleandneuralstemcelltherapyenhancesrecoveryinapigischemicstrokemodel AT faganmadisonm tanshinoneiialoadednanoparticleandneuralstemcelltherapyenhancesrecoveryinapigischemicstrokemodel AT scheulinkellym tanshinoneiialoadednanoparticleandneuralstemcelltherapyenhancesrecoveryinapigischemicstrokemodel AT sneedsydneye tanshinoneiialoadednanoparticleandneuralstemcelltherapyenhancesrecoveryinapigischemicstrokemodel AT cheeksavannahr tanshinoneiialoadednanoparticleandneuralstemcelltherapyenhancesrecoveryinapigischemicstrokemodel AT jeonjulieheejin tanshinoneiialoadednanoparticleandneuralstemcelltherapyenhancesrecoveryinapigischemicstrokemodel AT shinsook tanshinoneiialoadednanoparticleandneuralstemcelltherapyenhancesrecoveryinapigischemicstrokemodel AT kinderhollya tanshinoneiialoadednanoparticleandneuralstemcelltherapyenhancesrecoveryinapigischemicstrokemodel AT kumaranil tanshinoneiialoadednanoparticleandneuralstemcelltherapyenhancesrecoveryinapigischemicstrokemodel AT plattsimonr tanshinoneiialoadednanoparticleandneuralstemcelltherapyenhancesrecoveryinapigischemicstrokemodel AT dubersteinkyleej tanshinoneiialoadednanoparticleandneuralstemcelltherapyenhancesrecoveryinapigischemicstrokemodel AT parkheajin tanshinoneiialoadednanoparticleandneuralstemcelltherapyenhancesrecoveryinapigischemicstrokemodel AT xiejin tanshinoneiialoadednanoparticleandneuralstemcelltherapyenhancesrecoveryinapigischemicstrokemodel AT westfranklind tanshinoneiialoadednanoparticleandneuralstemcelltherapyenhancesrecoveryinapigischemicstrokemodel |